Therefore, the current study aimed to assess the potential utility of tissue lncRNA-H19 expression and circulating miR-675 as a non-invasive biomarker for potential HCC diagnosis and prognosis, as well as assessing changes in EGFR, VEGF, and cyclin D1 levels in hepatic tissue. Here, EGFR is linked to hepatocellular carcinoma.